SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Boston-based Ginkgo Bioworks has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results